Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NNFA In Brief: Nature's Source Absorbaid digestive enzymes

This article was originally published in The Tan Sheet

Executive Summary

Nature's Source Absorbaid digestive enzymes: Print ads for the "healthier option to antacids and acid blockers" will appear in October issues of Delicious, Energy Times, Natural Health and Vegetarian Times, the Niles, Ill.-based firm says. An ad also will appear in the September issue of New Product Review. Funding for the campaign totals $200,000. Absorbaid tablets, containing lipase, amylase, protease, cellulase and lactase, has been sold for human use for about two years in health food stores; the product first was sold as a veterinary product under the Prozyme name. A 90-count bottle retails for about $19.99, and 240-count for $49.99. The supplement is said to "help digest every food group more efficiently and effectively," removing "acid and food from the stomach and esophagus quickly, preventing the symptoms of indigestion and heartburn." Absorbaid also can relieve symptoms of indigestion "within minutes," the company claims...

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts